EUVIMEDEUVIMED entdecken
Crossref

Gallic acid relieved bortezomib-induced peripheral neurotoxicity by restoring Schwann cell lysosomal activity

Xiaoliang Liu, Ke Wang, Xingxian Zhang, Jiayu Qi, Danyan Zhu, Zechao Wang, Zhi He, Jianbiao Yao, Xiangnan Zhang iD, Jiaying Wu iD

Toxicological Sciences · 2025

DOI: 10.1093/toxsci/kfaf032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicological Sciences, 2025. Verfasst von Xiaoliang Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology and Toxicology, National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang Collaborative Innovation Ce…. Hauptthemen laut MEDLINE: Schwann Cells, Lysosomes, Bortezomib, Gallic Acid. Die Arbeit nennt 66 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Chinese Pharmaceutical Association-Servier Youth Hospital Pharmaceutical Innovation Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bortezomib (BTZ) serves as a first-line medication for multiple myeloma (MM) therapy. Unfortunately, despite its prominent efficacy in MM therapy, BTZ-induced peripheral neuropathy (BIPN) presents a significant challenge for patients lacks an established therapeutic solution. Previous research has demonstrated the involvement of lysosomal dysfunction in Schwann cells as a key in the pathological process of BIPN, suggesting that agents enhancing lysosomal activity could hold promise as a treatment for BIPN. Gallic acid (GA) is a natural compound known to preserve lysosomal integrity. However, it remains unidentified whether GA is effective in ameliorating BIPN. The administration of GA in mice demonstrated a significant reversal of BTZ-induced mechanical hypersensitivity, reduction in tail nerve conduction velocity, and demyelination of the sciatic nerve. GA counteracted BTZ-induced lysosomal dysfunction as evidenced by DQ-Red-BSA staining in RSC96 Schwann cells. BTZ-induced lysosomal protein loss and autophagic flux blockage were also hindered by GA. Further analysis revealed that BTZ resulted in the increased phosphorylation of transcription factor EB (TFEB) and reduced nuclear translocation of TFEB in RSC96 cells, and these effects were reversed upon GA treatment. Importantly, GA did not compromise the cytotoxic effects of BTZ on RPMI 8226 cells, indicating little interference with the pharmacological effects of BTZ. In summary, this study provides compelling evidence that GA can ameliorate BIPN in mice. GA activated TFEB signaling, promoted the lysosomal activity, and thus restored autophagy flux in Schwann cells exposed to BTZ. These findings underscore the potential of GA as a promising therapeutic intervention for BIPN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Schwann CellsLysosomesBortezomibGallic AcidPeripheral Nervous System DiseasesAntineoplastic AgentsNeurotoxicity SyndromesAnimalsMaleSciatic NerveAutophagyMiceMice, Inbred C57BLBasic Helix-Loop-Helix Leucine Zipper Transcription Factors

Stichwörter der Autor:innen

autophagybortezomibgallic acidlysosomeperipheral neuropathy

Substanzen

BortezomibGallic AcidAntineoplastic AgentsTcfeb protein, mouseBasic Helix-Loop-Helix Leucine Zipper Transcription Factors

Autor:innen und Institutionen

  • Institute of Pharmacology and Toxicology, National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang Collaborative Innovation Center for the Brain Diseases with Integrative Medicine, Zhejiang Key La…
  • College of Medicine and Health Sciences, China Three Gorges University, Yichang 443002, China.
  • Department of Pharmacology, College of Medicine, Jiaxing University, Jiaxing 314001, China.
  • Zhejiang Conba Pharmaceutical Co., Ltd., Hangzhou 310051, China.
  • Jinhua Institute of Zhejiang University, Jinhua 321299, China.
  • Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310002, China.

ORCID-Profile: Xiangnan Zhang, Jiaying Wu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • Chinese Pharmaceutical Association-Servier Youth Hospital Pharmaceutical Innovation Research Funding
  • Science and Technology
  • Zhejiang Pharmaceutical Association
  • Chinese Pharmaceutical Association—Servier Youth Hospital Pharmaceutical Innovation Research Funding

Zitieren

APA

Liu, X., Wang, K., Zhang, X., Qi, J., Zhu, D., Wang, Z., He, Z., Yao, J., Zhang, X., & Wu, J. (2025). Gallic acid relieved bortezomib-induced peripheral neurotoxicity by restoring Schwann cell lysosomal activity. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfaf032

Vancouver

Liu X, Wang K, Zhang X, Qi J, Zhu D, Wang Z, et al. Gallic acid relieved bortezomib-induced peripheral neurotoxicity by restoring Schwann cell lysosomal activity. Toxicological Sciences. 2025. doi:10.1093/toxsci/kfaf032

BibTeX
@article{Liu2025,
  author = {Liu, Xiaoliang and Wang, Ke and Zhang, Xingxian and Qi, Jiayu and Zhu, Danyan and Wang, Zechao and He, Zhi and Yao, Jianbiao and Zhang, Xiangnan and Wu, Jiaying},
  title = {Gallic acid relieved bortezomib-induced peripheral neurotoxicity by restoring Schwann cell lysosomal activity},
  journal = {Toxicological Sciences},
  year = {2025},
  doi = {10.1093/toxsci/kfaf032}
}
Kostenlos starten →